Efficacy and Safety Study of QVA149 in COPD Patients

NCT02487446 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

357

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: QVA149
DRUG: Umeclidinium/vilanterol
DRUG: Placebo (umeclidinium/vilanterol)
DRUG: Placebo (QVA149)

Sponsor

Novartis Pharmaceuticals